P.3.c.064 Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

MLA

M. Holdrup, et al. “P.3.c.064 Interventions in Antipsychotics-Treated Patients with Cardiometabolic Risk Factors or Metabolic Syndrome.” European Neuropsychopharmacology, vol. 18, Aug. 2008, pp. S440–41. EBSCOhost, https://doi.org/10.1016/s0924-977x(08)70648-5.

APA

M. Holdrup, John Teilmann Larsen, C. Sigalin, B. Christensen, S. Kolb, & Peter Nilsson. (2008). P.3.c.064 Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome. European Neuropsychopharmacology, 18, S440–S441. https://doi.org/10.1016/s0924-977x(08)70648-5

Chicago

M. Holdrup, John Teilmann Larsen, C. Sigalin, B. Christensen, S. Kolb, and Peter Nilsson. 2008. “P.3.c.064 Interventions in Antipsychotics-Treated Patients with Cardiometabolic Risk Factors or Metabolic Syndrome.” European Neuropsychopharmacology 18 (August): S440–41. doi:10.1016/s0924-977x(08)70648-5.